Forum on Drug Discovery, Development, and Translation
43 works on record
Works

Understanding the benefits and risks of pharmaceuticals
Accelerating the Development of New Drugs and Diagnostics : Maximizing the Impact of the Cures Acceleration Network
Facing the Reality of Drug-Resistant Tuberculosis in India

Building a National Framework for the Establishment of Regulatory Science for Drug Development

Envisioning a Transformed Clinical Trials Enterprise in the United States : Establishing an Agenda for 2020

Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa
Sharing Clinical Research Data
Examining the Impact of Real-World Evidence on Medical Product Development
Real-World Evidence Generation and Evaluation of Therapeutics
Rapid Medical Countermeasure Response to Infectious Diseases : Enabling Sustainable Capabilities Through Ongoing Public- And Private-Sector Partnerships

Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products

Enabling Precision Medicine : The Role of Genetics in Clinical Drug Development

Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the Brics

Reflections on Sharing Clinical Trial Data : Challenges and a Way Forward

Drug Research and Development for Adults Across the Older Age Span
Role of Digital Health Technologies in Drug Development
Envisioning a Transformed Clinical Trials Enterprise For 2030
Innovation in Drug Research and Development for Prevalent Chronic Diseases
Accelerating the Development of Biomarkers for Drug Safety
Emerging Safety Science
Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa : Global and Local Challenges and Solutions
Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS : Challenges and Opportunities
Advancing the Discipline of Regulatory Science for Medical Product Development : An Update on Progress and a Forward-Looking Agenda
Public Health Emergency Medical Countermeasures Enterprise : Innovative Strategies to Enhance Products from Discovery Through Approval
Public Engagement and Clinical Trials : New Models and Disruptive Technologies
Facing the Reality of Drug-Resistant Tuberculosis in India : Challenges and Potential Solutions
Advancing Regulatory Science for Medical Countermeasure Development
Building a National Framework for the Establishment of Regulatory Science for Drug Development
Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development
Breakthrough Business Models : Drug Development for Rare and Neglected Diseases and Individualized Therapies
Transforming Clinical Research in the United States : Challenges and Opportunities
New Profile of Drug-Resistant Tuberculosis in Russia : A Global and Local Perspective
Addressing the Barriers to Pediatric Drug Development
Challenges for the FDA : The Future of Drug Safety
Virtual Clinical Trials : Challenges and Opportunities
Inclusion of Pregnant and Lactating Persons in Clinical Trials
Adverse Drug Event Reporting : The Roles of Consumers and Health-Care Professionals
Financial Incentives to Encourage Development of Therapies That Address Unmet Medical Needs for Nervous System Disorders
Defining and Evaluating in-Home Drug Disposal Systems for Opioid Analgesics
Characterizing Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products
Addressing Treatment Resistance in the Development of Cancer Immune Modulator Therapeutics
Toward a Framework to Improve Diversity and Inclusion in Clinical Trials
Adult Attention-Deficit/Hyperactivity Disorder : Diagnosis, Treatment, and Implications for Drug Development